Number of the records: 1  

Lucifensin, a Novel Insect Defensin of Medicinal Maggots: Synthesis and Structural Study

  1. 1.
    SYSNO ASEP0364530
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleLucifensin, a Novel Insect Defensin of Medicinal Maggots: Synthesis and Structural Study
    Author(s) Čeřovský, Václav (UOCHB-X) RID, ORCID
    Slaninová, Jiřina (UOCHB-X)
    Fučík, Vladimír (UOCHB-X) RID
    Monincová, Lenka (UOCHB-X)
    Bednárová, Lucie (UOCHB-X) RID, ORCID
    Maloň, Petr (UOCHB-X)
    Štokrová, Jitka (UOCHB-X)
    Number of authors7
    Source TitleChembiochem. - : Wiley - ISSN 1439-4227
    Roč. 12, č. 9 (2011), s. 1352-1361
    Number of pages10 s.
    Languageeng - English
    CountryDE - Germany
    Keywordsantimicrobial peptide ; disulfide bridge ; lucifensin ; solid phase synthesis
    Subject RIVCC - Organic Chemistry
    R&D ProjectsGA203/08/0536 GA ČR - Czech Science Foundation (CSF)
    CEZAV0Z40550506 - UOCHB-X (2005-2011)
    UT WOS000292096100011
    DOI10.1002/cbic.201100066
    AnnotationLucifensin, a novel insect defensin of medicinal maggots identified recently in our laboratory, is 40 amino acid residues and three intramolecular bridges peptide. Oxidative folding of linear lucifensin precursor prepared by solid phase peptide synthesis resulted in a peptide with a pattern of disulfide bridges identical to that of native lucifensin. Synthetic lucifensin was active against Gram-positive bacteria and was not hemolytic. The presence of disulfide bridges and the N-terminal part of its molecule for the structure and antimicrobial activity is essential.
    WorkplaceInstitute of Organic Chemistry and Biochemistry
    Contactasep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Viktorie Chládková, Tel.: 232 002 434
    Year of Publishing2012
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.